Atlas Trials

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

Clinical trial NCT04868981 · COMPLETED

Trial details

NCT number
NCT04868981
Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2021-05-31
Primary completion
2022-02-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.